These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1114337)

  • 1. Inhibition of catecholamine release by tolbutamide and other sulfonylureas.
    Hsu CY; Brooker G; Peach MJ; Westfall TC
    Science; 1975 Mar; 187(4181):1086-7. PubMed ID: 1114337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential activities of tolbutamide, tolazamide, and glyburide in vitro on rabbit myocardial membrane Ca2+-transporting ATPase activity.
    Warnick PR; Davis FB; Davis PJ; Mylotte KM; Blas SD
    Diabetes; 1986 Sep; 35(9):1044-8. PubMed ID: 2943619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Voltage-independent catecholamine release mediated by the activation of muscarinic receptors in guinea-pig adrenal glands.
    Nakazato Y; Ohga A; Oleshansky M; Tomita U; Yamada Y
    Br J Pharmacol; 1988 Jan; 93(1):101-9. PubMed ID: 3349226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dopaminergic receptor modulates catecholamine release from the cat adrenal gland.
    Artalejo AR; García AG; Montiel C; Sánchez-García P
    J Physiol; 1985 May; 362():359-68. PubMed ID: 4020691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of muscarinic agonists on the release of (3H)noradrenaline from the guinea-pig perfused heart.
    Westfall TC; Hunter PE
    J Pharm Pharmacol; 1974 Jun; 26(6):458-60. PubMed ID: 4154994
    [No Abstract]   [Full Text] [Related]  

  • 6. [Subcellular distribution of pyrocatecholamines in heart and adrenal glands of guinea pigs after preliminary treatment with l-alpha-methyldopa].
    Grobecker H; Schümann HJ
    Experientia; 1966 Jan; 22(1):22-3. PubMed ID: 5915124
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of muscarine on release of catecholamines from the perfused adrenal gland of the cat.
    Kirpekar SM; Prat JC; Schiavone MT
    Br J Pharmacol; 1982 Nov; 77(3):455-60. PubMed ID: 7139197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective unresponsiveness of pancreatic beta-cells to acute sulfonylurea stimulation during sulfonylurea therapy in NIDDM.
    Karam JH; Sanz N; Salamon E; Nolte MS
    Diabetes; 1986 Dec; 35(12):1314-20. PubMed ID: 3533680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dopaminergic receptor in adrenal medulla as a possible site of action for the droperidol-evoked hypertensive response.
    Montiel C; Artalejo AR; Bermejo PM; Sánchez-García P
    Anesthesiology; 1986 Nov; 65(5):474-9. PubMed ID: 3777477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of the sulfonylurea HB 419 (glibenclamide), tolbutamide and tolazamide on the lipolysis of isolated human fat cells].
    Faulhaber JD; Ditschuneit H; Ditschuneit HH
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1476-8. PubMed ID: 5394469
    [No Abstract]   [Full Text] [Related]  

  • 11. Peptide antagonists of angiotensin-induced adrenal catecholamine release.
    Ackerly JA; Sarstedt CA; Peach MJ
    Eur J Pharmacol; 1977 Apr; 42(4):391-401. PubMed ID: 856615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of craniocerebral trauma on catecholamine metabolism in the heart, liver and adrenals of guinea pigs].
    Shirinian EA
    Vopr Med Khim; 1971; 17(6):640-4. PubMed ID: 5147937
    [No Abstract]   [Full Text] [Related]  

  • 13. Catecholamine release evoked by lithium from the perfused adrenal gland of the cat.
    Abajo FJ; Castro MA; Garijo B; Sánchez-García P
    Br J Pharmacol; 1987 Jul; 91(3):539-46. PubMed ID: 3607367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of hypertonic solutions on catecholamine release from cat adrenal glands.
    Ladona MG; Sanchez-García P; García AG
    Neuroscience; 1984 May; 12(1):301-7. PubMed ID: 6462450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of neosurugatoxin on evoked catecholamine secretion from bovine adrenal chromaffin cells.
    Bourke JE; Bunn SJ; Marley PD; Livett BG
    Br J Pharmacol; 1988 Feb; 93(2):275-80. PubMed ID: 2896033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfonylureas and the heart.
    Levey GS; Lasseter KC; Palmer RF
    Annu Rev Med; 1974; 25():69-74. PubMed ID: 4363211
    [No Abstract]   [Full Text] [Related]  

  • 17. Sulfonylureas stimulate renin secretion from the perfused kidney of the rat.
    Ochi H; Ikeda T
    Nephron; 1999 Jan; 81(1):67-71. PubMed ID: 9884422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfonylureas enhance exocytosis from pancreatic beta-cells by a mechanism that does not involve direct activation of protein kinase C.
    Tian YA; Johnson G; Ashcroft SJ
    Diabetes; 1998 Nov; 47(11):1722-6. PubMed ID: 9792541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental studies on the mechanism of thrombocyte aggregation inhibition caused by sulfonylurea compounds. 2. Modification of blood sugar and thrombocyte aggregation by oral antidiabetics].
    Losert W; Hoder A; Scholz C
    Arzneimittelforschung; 1975 Feb; 25(2):170-9. PubMed ID: 804311
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of ATP-sensitive K+ channel blockers on the action potential shortening in hypoxic and ischaemic myocardium.
    Nakaya H; Takeda Y; Tohse N; Kanno M
    Br J Pharmacol; 1991 May; 103(1):1019-26. PubMed ID: 1908730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.